Biogen and Bio-Thera Announce Positive Phase 3 Study of BAT1806, Biosimilar to Actemra® (Tocilizumab)
Biogen Inc. and Bio-Thera Solutions, Ltd. today announced results from the Phase 3 study of BAT1806, ...
Read moreBiogen Inc. and Bio-Thera Solutions, Ltd. today announced results from the Phase 3 study of BAT1806, ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.